I https://i-uv.com

  • Home
    • “Meetups” and Connecting with Your Soul Groups
      • Contact Sister Sites
  • OPPT Absolute
    • OPPT Tools
      • OPPT FAQ
      • The Foreclosure Flyer
      • OPPT Courtesy Notice
      • OPPT CN Guidelines
      • Which Courtesy Notice?
      • Cover Letters for CNs
      • Translations of Courtesy Notice
      • Public Interest Courtesy Notice: Monsanto
        • Public Interest Courtesy Notice: IRS
        • Public Interest Courtesy Notice: Chemtrails
        • FREEdom Flyer
    • OPPT Tool Complete
    • OPPT Goes Public
      • OPPT Definitions
      • OPPT Press Releases
      • Conversation with Heather & Brian
    • OPPT Initial Investigation
      • Original OPPT UCC Filings
      • OPPT Financing Statement July 25 2012
      • OPPT True Bill UCC Filing
      • OPPT Commercial Bill UCC Filing
      • Declaration of Facts
      • OPPT UCC Filings in CNs
      • The One People’s Public Trust (OPPT): Your Frequently Asked Questions…ANSWERED
      • E_Call Supporting Documents
  • I UV
    • HATJ: Trust ~ ALL ON!!!
      • Documents for Proof of Ownership for Funds
      • TDDA : Testing spread sheet
    • I and the UV Exchange
    • Heather Ann Tucci-Jarraf : I AM WITHOUT PREJUDICE
    • The Will and The Word of I
    • I UV GIFT HAS BEEN ACCEPTED
  • Media and News
    • Nova Earth News
    • Radio Shows
      • The One People Radio Show
      • The Collective Imagination
      • The Transitioning Radio Show
    • Show Transcripts
    • Radio Interviews
  • Freedom Stories
    • Share Your Freedom Story With The World
    • Checklist for Some BEing and DOing
  • Removing The Veil
    • Banking Industry Quarterly Reports
    • Our Cosmic Community
      • Friends in ‘High’ Places
      • Share Your Stories of Friends in ‘High’ Places
  • I UV Blog
    • Contact Us
    • Gold Meditations

Yale epidemiologist: Dr. Fauci running ‘misinformation campaign’ against hydroxychloroquine

by BZ ⒾAM Riger / Thursday, 30 July 2020 / Published in China Virus Unmasked

 

 

Yale epidemiologist: Dr. Fauci running ‘misinformation campaign’ against hydroxychloroquine

Accuses prominent doctor of harboring ‘total anti-science viewpoint.’

By Daniel Payne, published on Just The News, on  July 30, 2020

Dr. Harvey Risch, a noted Yale epidemiologist,  has accused White House coronavirus task force member Dr. Anthony Fauci of waging a “misinformation campaign” against the drug hydroxychloroquine, claiming the medication has shown consistently encouraging results in treating COVID-19 when used properly.

Hydroxychloroquine has been at the center of a protracted political debate since March, when President Trump cited the drug as a promising possible treatment for the novel coronavirus. HCQ has long been used by doctors to treat malaria along with other syndromes such as arthritis and lupus. The World Health Organization lists it as an essential medicine, while nearly five million Americans hold prescriptions for it.

Since Trump’s speculative endorsement of the drug, media outlets and medical officials have for several months aggressively promoted various medical trials that have determined the drug has no effectiveness in fighting COVID-19; many commentators have also insisted, in spite of the drug’s decades-long safe track record, that it is too dangerous to be used to cure the disease.

Among the drug’s critics has been Fauci. In March, the longtime director of the National Institute of Allergy and Infection Diseases dismissed claims of HCQ’s effectiveness as “anecdotal” and has periodically voiced that skepticism over the course of the pandemic.

On Tuesday during an interview on “Good Morning America,” Fauci further downplayed the drug’s purported benefit, claiming that “the overwhelming prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in [treating] coronavirus disease.”

Drug is ‘the key to defeating COVID-19,’ says infectious disease expert

Risch, however, is sharply criticizing Fauci’s approach to evaluating the drug’s effectiveness, arguing that repeated trials and tests have shown that it is markedly effective at treating COVID-19 so long as it is administered properly.

Risch, a professor of epidemiology and the director of Yale’s Molecular Cancer Epidemiology Laboratory, has been pushing for the drug’s use in the fight against the coronavirus for months. Last week in a Newsweek op-ed he called HCQ “the key to defeating COVID-19,” claiming its use — particularly when administered with one of two antibiotics and the nutritional supplement zinc — has been “shown to be highly effective” in treating high-risk coronavirus patients.

On Tuesday, Risch went further, charging in an interview with Just the News that Fauci is perpetrating a “misinformation campaign” in his opposition to the drug.

Fauci “has been maintaining a studious position that only randomized controlled trial evidence has any value,” Risch said, “and everything else he calls anecdotal.”

Randomized controlled trials have been referred to as “the gold standard” of clinical research experiments; Fauci last month lamented the “paucity” of such trials regarding COVID-19 cures. But Risch said numerous other types of studies have significant practical value in determining effective courses of medical treatment.

Risch shared a 2017 New England Journal of Medicine article by former Centers for Disease Control and Prevention Director Tom Frieden, one in which the author argued that randomized controlled trials have “substantial limitations” and that “many other data sources can provide valid evidence for clinical and public health action.”

Five key factors for successful HCQ treatment, Risch says

Fauci’s office did not respond to requests for comment on Risch’s claims about the drug’s effectiveness and Fauci’s assessment of it.

Risch argued that, while hydroxychloroquine is not a universally effective treatment, it has shown marked and repeated success when used in appropriate cases and at appropriate points of disease progression.

“The crucial issues are (a) early treatment of (b) high-risk (c) outpatients with (d) HCQ plus zinc, [azithromycin], doxycycline etc. for (e) hospitalization or mortality outcomes,” Risch said. “Dr. Fauci, in citing all of the studies without qualification, smeared all over points (a)-(e).”

Risch said opponents of HCQ have been arguing that the drug “doesn’t work on patients near death in ventilators and therefore we can’t use it on healthier patients in outpatient settings.”

“Why would you even entertain invoking a study on severely sick patients to bear on the efficacy of outpatients?” he asked.

Risch provided Just the News with several studies and reports he said demonstrated the drug’s effectiveness. One report out of India earlier this month stated that the drug appeared effective in reducing the virility of the disease, with patients who took larger doses apparently less likely to spread it to close contacts.

One scholarly article published in Travel Medicine and Infectious Disease last month detailed experiments by researchers in Marseille, France, who treated over 3,100 patients with a combination of hydroxychloroquine and azithromycin. That treatment regimen was “associated with a decreased risk of transfer to ICU or death … decreased risk of hospitalization ≥10 days … and shorter duration of viral shedding,” the researchers wrote.

(That study appeared to use hospitalized patients as trial subjects, but Risch said that the facility functions as both an inpatient ward and a day clinic. “During the study, HCQ was not legal to prescribe for outpatients,” he said. “So the hospital admitted patients for the day, did exams etc. and gave them the HCQ prescriptions, then they went home.  Only a small number were actually hospitalized. So in reality they were outpatients.”)

Researchers in Brazil, meanwhile, said that patients treated with hydroxychloroquine and azithromycin were less likely to be hospitalized, particularly the earlier the treatment was started. Risch also shared an open letter written in late April by upstate New York doctor Vladimir Zelenko in which the doctor said he had observed “very positive results” by treating patients with hydroxychloroquine, azithromycin and zinc. Of 405 patients treated with that regimen, Zelenko wrote, two died, six were hospitalized, and four were intubated.

In a July 20 academic letter, Risch ultimately cited a total of 12 studies he said showed a positive association with HCQ use and improved mortality outcomes, including one trial in New York City concluding that “hydroxychloroquine use was associated with decreased in-hospital mortality.”

Risch said that the practice of treating sicker patients with the drug “favors a poorer outcome for the medication.”

“The evidence is when you limit studies to just the five conditions outlined in my first email, [the drug] shows benefits in those strict conditions,” Risch said.

RCTs have indicated the drug is not effective at COVID-19

Numerous randomized controlled trials have indeed suggested that hydroxychloroquine has little to no effect in treating coronavirus.

One such study, the results of which were published last month, utilized a “randomized, double-blind, placebo-controlled trial across the United States and parts of Canada” testing whether or not the drug could work as “postexposure prophylaxis.” Though “no serious adverse reactions were reported” by those taking the drug, hydroxychloroquine “did not prevent illness compatible with Covid-19 or confirmed infection” when used in that manner.

Those conclusions would seem to dispute Risch’s claims that the drug is most effective at counteracting COVID-19 when used early, though the researchers themselves acknowledged the significant limitations of their own study: Just 18% of those classified as COVID patients in the study actually confirmed that diagnosis with a laboratory test. “Given the small number of PCR tests,” the researchers state at one point, “it remains theoretically possible that hydroxychloroquine therapy limits proven infection.”

Two other randomized controlled studies, one published in the medical journal BMJ in May and one conducted by the U.K.’s Nuffield Health System concluded that hydroxychloroquine use “did not result in a significantly higher probability of negative conversion than standard of care alone” and that there was “no beneficial effect of hydroxychloroquine” in the studied patient populations.

Notably, both of those studies utilized patients who had been hospitalized for COVID-19 rather than those at the earlier stages of the disease; according to Risch, the drug is less effective under those conditions and should be given at the earliest point possible in the disease’s progression, outside of a hospital setting.

“All we want is to show benefit under those conditions,” Risch told Just the News. “We don’t need to use this medication in the hospital because the whole point is to keep patients out of the hospital.”

Share
  • Tweet

About BZ ⒾAM Riger

What you can read next

CORONA VIRUS IN FCI- ALICEVILLE
A global team of experts has found 10 FATAL FLAWS in the main test for Covid and is demanding it’s urgently axed. As they should
Michigan County Board Approves Resolution to Impeach Gov. Whitmer

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow ~ I UV Blog
enter Primary email:
Must confirm email for Success

Delivered by FeedBurner

Share What You See

Share
Thank you for your exchange of value with us
If you find value in the I UV website & blog , enjoy the content , and appreciate the energy put into it for you, please consider returning some energy by making a donation.~ BZ

Updates

  • #UNIVERSALCLEANUP: HATJ & RKB Alleged Trial Transcripts w RKB Closing Statements
  • #UniversalCleanUp: EO 13818 & Letter from the President to the Congress of the United States
    • Quantum Playground: #HATJ #POTUS : “Universal Clean Up” & “Universal Backdoor”
  • Current Updates HATJ & RKB
    • Eastern District TN Court updates
    • Knox County Sheriffs Office Inmate Manual 2018
  • IRS Secret Manual for Agents 1982
  • Court Registry Investment System- CRIS
  • I and the UV Exchange

Recent Comments

  • Jake Sydney on ThreadvUpdated : Simon Parkes Update Series- 11.4 thru 1.16
  • Leledogz on President Trump Just Signed Into Law- The Storm Act- 1.1.2021
  • Mark on President Trump Just Signed Into Law- The Storm Act- 1.1.2021
  • Mim on OPPT Initial Investigation: The Paradigm Report
  • miles e drake on Text of a Letter to the Speaker of the House of Representatives and the President of the Senate
  • Michele Knight on Marine Corps. Rebukes Pelosi: “WE DON’T WORK FOR YOU!”
  • larry real on Terran Cognito: A Letter from Heather dated 1-5-2021 Universal Security Agreement America!

Recent BEing & DOing

  • Quantum Playground
  • Expansion Meme
  • HATJ
  • Absolute Data
  • Abilities
  • Eternal Essence Embodied
  • Disclosure
  • Creative Arts
  • Freedom Stories
  • Removing the Veil
  • China Virus Unmasked
  • Deep State-Illuminati
  • Satanic Ritual Abuse SRA
  • Sex trafficking

Removing The Veil

  • HATJ: Trust ~ ALL ON!!!
  • OPPT Absolute
  • The Slavery System
  • Banking
  • Chemtrails
  • #UniversalCleanUp :History of Banking
  • Modern Money Mechanics
  • Top Secret Banker’s Manual
  • #UniversalCleanUp : Money & Banking Dallas
  • I Bet You Thought
  • Your Strawman
  • Clinton Body Count List Infographic

Archives

www.i-uv.com all content © Eternal Essence Embodied ©2020

TOP